Apoptosis(凋亡)
As one of the cellular death mechanisms, apoptosis, also known as programmed cell death, can be defined as the process of a proper death of any cell under certain or necessary conditions. Apoptosis is controlled by the interactions between several molecules and responsible for the elimination of unwanted cells from the body.
Many biochemical events and a series of morphological changes occur at the early stage and increasingly continue till the end of apoptosis process. Morphological event cascade including cytoplasmic filament aggregation, nuclear condensation, cellular fragmentation, and plasma membrane blebbing finally results in the formation of apoptotic bodies. Several biochemical changes such as protein modifications/degradations, DNA and chromatin deteriorations, and synthesis of cell surface markers form morphological process during apoptosis.
Apoptosis can be stimulated by two different pathways: (1) intrinsic pathway (or mitochondria pathway) that mainly occurs via release of cytochrome c from the mitochondria and (2) extrinsic pathway when Fas death receptor is activated by a signal coming from the outside of the cell.
Different gene families such as caspases, inhibitor of apoptosis proteins, B cell lymphoma (Bcl)-2 family, tumor necrosis factor (TNF) receptor gene superfamily, or p53 gene are involved and/or collaborate in the process of apoptosis.
Caspase family comprises conserved cysteine aspartic-specific proteases, and members of caspase family are considerably crucial in the regulation of apoptosis. There are 14 different caspases in mammals, and they are basically classified as the initiators including caspase-2, -8, -9, and -10; and the effectors including caspase-3, -6, -7, and -14; and also the cytokine activators including caspase-1, -4, -5, -11, -12, and -13. In vertebrates, caspase-dependent apoptosis occurs through two main interconnected pathways which are intrinsic and extrinsic pathways. The intrinsic or mitochondrial apoptosis pathway can be activated through various cellular stresses that lead to cytochrome c release from the mitochondria and the formation of the apoptosome, comprised of APAF1, cytochrome c, ATP, and caspase-9, resulting in the activation of caspase-9. Active caspase-9 then initiates apoptosis by cleaving and thereby activating executioner caspases. The extrinsic apoptosis pathway is activated through the binding of a ligand to a death receptor, which in turn leads, with the help of the adapter proteins (FADD/TRADD), to recruitment, dimerization, and activation of caspase-8 (or 10). Active caspase-8 (or 10) then either initiates apoptosis directly by cleaving and thereby activating executioner caspase (-3, -6, -7), or activates the intrinsic apoptotic pathway through cleavage of BID to induce efficient cell death. In a heat shock-induced death, caspase-2 induces apoptosis via cleavage of Bid.
Bcl-2 family members are divided into three subfamilies including (i) pro-survival subfamily members (Bcl-2, Bcl-xl, Bcl-W, MCL1, and BFL1/A1), (ii) BH3-only subfamily members (Bad, Bim, Noxa, and Puma9), and (iii) pro-apoptotic mediator subfamily members (Bax and Bak). Following activation of the intrinsic pathway by cellular stress, pro‑apoptotic BCL‑2 homology 3 (BH3)‑only proteins inhibit the anti‑apoptotic proteins Bcl‑2, Bcl-xl, Bcl‑W and MCL1. The subsequent activation and oligomerization of the Bak and Bax result in mitochondrial outer membrane permeabilization (MOMP). This results in the release of cytochrome c and SMAC from the mitochondria. Cytochrome c forms a complex with caspase-9 and APAF1, which leads to the activation of caspase-9. Caspase-9 then activates caspase-3 and caspase-7, resulting in cell death. Inhibition of this process by anti‑apoptotic Bcl‑2 proteins occurs via sequestration of pro‑apoptotic proteins through binding to their BH3 motifs.
One of the most important ways of triggering apoptosis is mediated through death receptors (DRs), which are classified in TNF superfamily. There exist six DRs: DR1 (also called TNFR1); DR2 (also called Fas); DR3, to which VEGI binds; DR4 and DR5, to which TRAIL binds; and DR6, no ligand has yet been identified that binds to DR6. The induction of apoptosis by TNF ligands is initiated by binding to their specific DRs, such as TNFα/TNFR1, FasL /Fas (CD95, DR2), TRAIL (Apo2L)/DR4 (TRAIL-R1) or DR5 (TRAIL-R2). When TNF-α binds to TNFR1, it recruits a protein called TNFR-associated death domain (TRADD) through its death domain (DD). TRADD then recruits a protein called Fas-associated protein with death domain (FADD), which then sequentially activates caspase-8 and caspase-3, and thus apoptosis. Alternatively, TNF-α can activate mitochondria to sequentially release ROS, cytochrome c, and Bax, leading to activation of caspase-9 and caspase-3 and thus apoptosis. Some of the miRNAs can inhibit apoptosis by targeting the death-receptor pathway including miR-21, miR-24, and miR-200c.
p53 has the ability to activate intrinsic and extrinsic pathways of apoptosis by inducing transcription of several proteins like Puma, Bid, Bax, TRAIL-R2, and CD95.
Some inhibitors of apoptosis proteins (IAPs) can inhibit apoptosis indirectly (such as cIAP1/BIRC2, cIAP2/BIRC3) or inhibit caspase directly, such as XIAP/BIRC4 (inhibits caspase-3, -7, -9), and Bruce/BIRC6 (inhibits caspase-3, -6, -7, -8, -9).
Any alterations or abnormalities occurring in apoptotic processes contribute to development of human diseases and malignancies especially cancer.
References:
1.Yağmur Kiraz, Aysun Adan, Melis Kartal Yandim, et al. Major apoptotic mechanisms and genes involved in apoptosis[J]. Tumor Biology, 2016, 37(7):8471.
2.Aggarwal B B, Gupta S C, Kim J H. Historical perspectives on tumor necrosis factor and its superfamily: 25 years later, a golden journey.[J]. Blood, 2012, 119(3):651.
3.Ashkenazi A, Fairbrother W J, Leverson J D, et al. From basic apoptosis discoveries to advanced selective BCL-2 family inhibitors[J]. Nature Reviews Drug Discovery, 2017.
4.McIlwain D R, Berger T, Mak T W. Caspase functions in cell death and disease[J]. Cold Spring Harbor perspectives in biology, 2013, 5(4): a008656.
5.Ola M S, Nawaz M, Ahsan H. Role of Bcl-2 family proteins and caspases in the regulation of apoptosis[J]. Molecular and cellular biochemistry, 2011, 351(1-2): 41-58.
Products for Apoptosis
- Caspase(99)
- 14.3.3 Proteins(1)
- Apoptosis Inducers(43)
- Bax(7)
- Bcl-2 Family(120)
- Bcl-xL(8)
- c-RET(9)
- IAP(27)
- KEAP1-Nrf2(66)
- MDM2(12)
- p53(123)
- PC-PLC(4)
- PKD(7)
- RasGAP (Ras- P21)(1)
- Survivin(8)
- Thymidylate Synthase(10)
- TNF-α(145)
- Other Apoptosis(883)
- APC(6)
- PD-1/PD-L1 interaction(90)
- ASK1(3)
- PAR4(2)
- RIP kinase(52)
- FKBP(20)
- Pyroptosis(31)
- Cat.No. 产品名称 Information
-
GC60153
Eriocalyxin B
毛萼乙素
EriocalyxinB是从中草药枇杷素中分离得到的一种二萜类化合物。EriocalyxinB具有抗癌、抗炎作用。EriocalyxinB诱导细胞凋亡(apoptosis)。 -
GC60111
Clitocine
克力托辛
Clitocine是一种腺苷核苷类似物,是一种有效的通透剂(readthrough)。Clitocine可诱导携带p53无义突变等位基因的细胞产生p53蛋白。Clitocine可通过靶向Mcl-1诱导多药耐药肿瘤细胞凋亡。具有抗癌活性。 -
GC60076
Bigelovin
锦菊素
Bigelovin是可从海百合中分离得到的一种倍半萜内酯,是选择性的视黄素X受体α(retinoidXreceptorα)的激动剂。Bigelovin可通过诱导凋亡和自噬来发挥抗肿瘤活性。Bigelovin通过抑制ROS的生成来调节mTOR信号通路。 -
GC60008
(S)-Verapamil hydrochloride
S-维拉帕米,(S)-(-)-Verapamil hydrochloride
(S)-Verapamil hydrochloride (S(-)-Verapamil hydrochloride) 通过 MRP1 抑制白三烯 C4 (LTC4) 和钙黄绿素的转运。(S)-Verapamil hydrochloride 导致潜在耐药性肿瘤细胞死亡。 -
GC18572
Concanavalin A
刀豆蛋白
Concanavalin A属于concanamycin,这是一种从异色链霉菌中分离出来的大环内酯类抗生素,是液泡质子- atp酶(v-[H[+]] atp酶)的高活性和选择性抑制剂。 -
GC18533
ZLDI-8
ZLDI-8 是一种 Notch 激活/切割酶 ADAM-17 抑制剂,可抑制 Notch 蛋白的切割。 ZLDI-8 降低促存活/抗凋亡和上皮间质转化 (EMT) 相关蛋白的表达。 ZLDI-8 还是一种竞争性且不可逆的酪氨酸磷酸酶 (Lyp) 抑制剂,IC50 为 31.6 μM,Ki 为 26.22 μM。 ZLDI-8 抑制 MHCC97-H 细胞的生长,IC50 为 5.32 μM。
-
GC39827
HM03
4-((6-氯-2-甲氧基吖啶-9-基)氨基)-2-((4-甲基哌嗪-1-基)甲基)苯酚
HM03 是一种有效的选择性的热休克 70 kDa 蛋白 5, HSPA5 (也称为 Bip,Grp78) 抑制剂,具有抗肿瘤活性。 -
GC39820
Lometrexol hydrate
洛美曲索水合物,DDATHF hydrate
A GART inhibitor -
GC39815
Semapimod tetrahydrochloride
CNI-1493; CPSI-2364 tetrahydrochloride
Semapimod tetrahydrochloride (CNI-1493) 是促炎细胞因子产生 (proinflammatory cytokine) 的抑制剂,可抑制TNF-α、IL-1β 和 IL-6。Semapimod tetrahydrochloride 抑制巨噬细胞 p38 MAPK 和一氧化氮生成。Semapimod tetrahydrochloride 抑制 TLR4 信号 (IC50≈0.3 μM)。Semapimod tetrahydrochloride 在多种炎症和自身免疫性疾病中具有潜在的作用。 -
GC39814
Mitoguazone
米托瓜酮; Methylglyoxal-bis(guanylhydrazone); MGBG; Methyl-GAG
Mitoguazone (Methylglyoxal-bis(guanylhydrazone)) 是一种具有有效抗肿瘤活性的合成多羰基衍生物。Mitoguazone 是一种可透过血脑屏障的竞争性的 S-腺苷-蛋氨酸脱羧酶 (S-adenosyl-methionine decarboxylase) 抑制剂,可破坏多胺的生物合成。Mitoguazone 诱导细胞凋亡 (apoptosis),可抑制 HIV DNA 整合到单核细胞和巨噬细胞中的细胞 DNA 中。Mitoguazone 具可用于急性白血病,霍奇金淋巴瘤和非霍奇金淋巴瘤的研究。 -
GC39808
Didesmethylrocaglamide
Didesmethylrocaglamide 是一种 Rocaglamide 的衍生物,也是一种有效的真核起始因子 4A (eIF4A) 抑制剂。Didesmethylrocaglamide 具有有效的生长抑制活性,IC50 为 5 nM。Didesmethylrocaglamide 抑制多种促进生长的信号通路,并诱导肿瘤细胞凋亡 (apoptosis)。抗肿瘤活性。
-
GC39798
Scoulerine
金黄紫堇碱,(-)-Scoulerine; Discretamine
A benzylisoquinoline alkaloid with diverse biological activities -
GC39719
Nigericin
尼日利亚霉素
A potassium ionophore
-
GC39708
DT2216
DT2216 是一种蛋白水解靶向嵌合体 (PROTAC),靶向 Bcl-xL 降解依赖于 Bcl-2 家族过表达蛋白(例如 Bcl-2、Bcl-xL 和 Mcl)的 T 细胞淋巴瘤-1.DT2216 抑制 G-68 细胞,IC50 值为 4.02 μM(72 小时)。
-
GC39707
Droloxifene
屈洛昔芬,3-Hydroxytamoxifen
A selective estrogen receptor modulator -
GC39699
Aurintricarboxylic acid
金精三羧酸
A protein synthesis inhibitor with diverse biological activities -
GC39640
GPLGIAGQ TFA
GPLGIAGQ TFA 是一种 MMP2 可切割的多肽,在脂质体和胶束纳米载体中都被用作刺激敏感的连接物,用于 MMP2 触发的肿瘤靶向治疗。GPLGIAGQ TFA可用于合成光动力治疗 (PDT) 中独特的 MMP2 靶向光敏剂。
-
GC39620
AKOS-22
AKOS-22 是一种有效的线粒体蛋白电压依赖性阴离子通道 1 (VDAC1) 抑制剂 (Kd=15.4 μM)。AKOS-22 与 VDAC1 相互作用,抑制 VDAC1 齐聚和凋亡。AKOS-22 对线粒体功能的保护作用。
-
GC39584
AGN194204
IRX4204; NRX194204; VTP 194204
AGN194204 (IRX4204) 是一种具有口服活性的,选择性 RXR 激动剂,对 RXRα,RXRβ 和 RXRγ 的 Kd 值分别为 0.4 nM,3.6 nM 和 3.8 nM,EC50 分别为 0.2 nM,0.8 nM 和 0.08 nM。AGN194204 对 RAR 无活性,并具有抗炎和抗癌作用。 -
GC39556
CDDO-3P-Im
CDDO-3P-Im 是 CDDO 咪唑胺类似物,具有化学预防作用。CDDO-3P-Im 可降低小鼠肺癌模型肺肿瘤的大小和严重程度。
-
GC39555
CDDO-2P-Im
CDDO-2P-Im 是 CDDO 咪唑胺类似物,具有化学预防作用。CDDO-2P-Im 可降低小鼠肺癌模型肺肿瘤的大小和严重程度。
-
GC39551
BRD3308
An HDAC3 inhibitor
-
GC39535
Yamogenin
雅姆皂甙元; Neodiosgenin
A steroidal sapogenin with diverse biological activities -
GC39503
PROTAC FKBP Degrader-3
PROTAC FKBP Degrader-3 是一种包含 FKBP 配体结合基团,linker 和 VHL 结合基团的 PROTAC。PROTAC FKBP Degrader-3 是一种有效的 FKBP 降解剂。
-
GC39500
PDK4-IN-1 hydrochloride
PDK4-IN-1 hydrochloride 是一种蒽醌衍生物,也是一种有效的,口服活性的丙酮酸脱氢酶激酶 4 (PDK4) 抑制剂,IC50 值为 84 nM。PDK4-IN-1 hydrochloride 有效抑制细胞转化和细胞增殖并诱导细胞凋亡 (apoptosis)。PDK4-IN-1 hydrochloride 具有抗糖尿病,抗癌和抗过敏作用。
-
GC39489
GPNA hydrochloride
Γ-(P-硝基苯胺)-L-谷氨酸盐酸盐
GPNA (L-γ-Glutamyl-p-nitroanilide) is a potent and selective inhibitor of the glutamine (Gln) transporter ASCT2(SLC1A5) with Ki of 55 ?M. -
GC39485
CK2/ERK8-IN-1
A dual inhibitor of CK2 and ERK8
-
GC39483
BO-264
A TACC3 inhibitor
-
GC39450
Tea polyphenol
茶多酚
Tea polyphenols are chemical compounds such as flavanoids and tannins found naturally in tea. Several biological properties have been associated to tea polyphenols (TP), including antioxidant, anti-carcinogenic and antimicrobial activities. -
GC39415
OR-1896
左西孟旦杂质
OR-1896 是 Levosimendan 的活性长寿代谢产物。OR-1896 是一种高选择性磷酸二酯酶 (PDE III) 抑制剂,是一种功能强大的血管扩张剂。OR-1896 可以打开 ATP 敏感的 K+ 通道,并具有 Ca2+ 致敏作用。OR-1896 可减轻心肌细胞的凋亡,心脏重塑和心肌炎症。 -
GC39382
FW1256
FW1256 是一种苯基类似物,也是一种缓释硫化氢 (H2S) 供体。FW1256 抑制 NF-κB 活性,并可诱导细胞凋亡 (apoptosis),并可用于癌症,炎症和心血管疾病的研究。
-
GC39377
EB-3D
EB-3D is a potent and selective inhibitor of choline kinase α (ChoKα) with IC50 of 1 μM for ChoKα1. EB-3D induces deregulation of the AMPK-mTOR pathway and apoptosis in leukemia T-cells.
-
GC39365
CPTH2
A HAT inhibitor
-
GC39355
BTSA1
BTSA1 is a pharmacologically optimized BAX activator that binds with high affinity and specificity to the N-terminal activation site and induces conformational changes to BAX leading to BAX-mediated apoptosis. It effectively promotes apoptosis in leukemia cell lines and patient samples while sparing healthy cells.
-
GC18416
ONO-7475
ONO-7475
An inhibitor of Axl and Mer -
GC50517
OD 36 hydrochloride
OD 36 hydrochloride 是一种 RIPK2 抑制剂,IC50 为 5.3 nM。
-
GC50482
(D)-PPA 1
An inhibitor of the PD-1-PD-L1 protein-protein interaction
-
GC50465
A 410099.1
N-甲基-L-丙氨酰-(2S)-2-环己基氨基乙酰基-N-[(1R)-1,2,3,4-四氢-1-萘基]-L-脯氨酰胺盐酸盐
High affinity XIAP antagonist; active in vivo -
GC50372
SK 216
Plasminogen activator inhibitor-1 (PAI-1) inhibitor
-
GC50368
INF 4E
INF 4E 是一种有效的 NLRP3 炎性体抑制剂。
-
GC50296
D9
D9 是一种有效的选择性硫氧还蛋白还原酶 (TrxR) 抑制剂,EC50 为 2.8 nM。 D9 具有在体外和体内抑制肿瘤增殖的能力。
-
GC50282
EC 19
Synthetic retinoid; induces differentiation of stem cells
-
GC50280
JX 06
NSC 402538
An irreversible PDHK inhibitor -
GC50253
PF 543 hydrochloride
Sphingosine Kinase 1 Inhibitor II hydrochloride
A potent inhibitor of SPHK1 -
GC50242
RA 839
RA 839 是 Keap1 的非共价小分子结合剂,Kd 约为 6 μM,是 Nrf2 信号传导的选择性激活剂。
-
GC50223
MSC 2032964A
Potent and selective ASK1 inhibitor; orally bioavailable
-
GC50196
Simvastatin - d6
六氘代辛伐他汀,MK 733-d6
An internal standard for the quantificaition of simvastatin -
GC50190
Fenretinide - d4
4-HPR-d4, 4-Hydroxy(phenyl)retinamide-d4, Retinoic Acid p-hydroxyphenylamide-d4
An internal standard for the quantification of fenretinide -
GC50141
SMBA 1
High affinity and selective activator of Bax
-
GC50118
S 07662
Constitutive androstane receptor (CAR) inverse agonist